- US11845931utility2023Crispr/cas Screening Platform to Identify Genetic Modifiers of Tau Seeding or Aggregation0 cites
- US11845957utility2023Models of Tauopathy0 cites
- US11845963utility2023HSD17B13 Variants and Uses Thereof0 cites
- USD1007676design2023Wearable Autoinjector0 cites
- US11834500utility2023Bispecific Antigen Binding Molecules That Bind Leptin Receptor And/or GP130, and Methods of Use Thereof0 cites
- US11834485utility2023IL-2 Variants with Reduced Binding to IL-2 Receptor Alpha and Uses Thereof0 cites
- US11835527utility2023Deglycosylation Methods for Electrophoresis of Glycosylated Proteins0 cites
- US11835528utility2023System and Method of Analysis of a Protein Using Liquid Chromatography-mass Spectrometry0 cites
- US11825819utility2023Crnn Loss of Function Rodent Model0 cites
- US11826386utility2023Compositions and Methods for Treating Cancer0 cites
- US11826196utility2023Medical Imaging Table, Table Support Assembly, Probe Support Assembly, System, and Method of Use0 cites
- US11823371utility2023Assembly Line with Integrated Electronic Visual Inspection0 cites
- US11820997utility2023Methods and Compositions for the Targeted Modification of a Genome0 cites
- US11821001utility2023Cell Culture Medium for Eukaryotic Cells0 cites
- US11820815utility2023Human Antibodies to Human Delta Like Ligand 40 cites
- US11820826utility2023Anti-npr1 Antibodies and Uses Thereof0 cites
- US11820982utility2023Treatment of Ophthalmic Conditions with Son of Sevenless 2 (SOS2) Inhibitors0 cites
- US11814428utility2023Anti-ptcra Antibody-drug Conjugates and Uses Thereof0 cites
- US11808766utility2023Method for Generating High Affinity Antibodies0 cites
- US11806398utility2023Citrate Buffered VEGF Antagonist Formulations0 cites